Pyridam Farma (PYFA) Records Significant Growth, Revenue Doubles with a Target of Rp 3 Trillion Next Year
PT Pyridam Farma Tbk (PYFA) and RGCC Forge Strategic Partnership, Bringing Cancer Treatment Innovation to Indonesia
PYFAGROUP’s Commitment to the Nation’s Health is Realized Through the Expansion of Ethica Industri Farmasi’s Injection Production Facility
Sales of Pyridam Farma Tbk and its subsidiaries (PYFA Group) Increase 127% to Rp. 630.5 Billion in 2021
Merz Therapeutics GmbH Together with Pyridam Farma Presents Innovative Products for the Indonesian Community
Seriously Entering Consumer Health Market, Pyridam Farma Launches Exclusive Pyfahealth Brand At Tokopedia
PT. Pyridam Farma Tbk (PYFA) Creates #GerakanSejutaVitamin Campaign, Ready to Distribute Free Vitamins to Indonesian People
Supporting the Highest Retail Price (HET) Decision From the Government, PT Pyridam Farma Tbk. Prioritize the Production of Azithromycin and D3-1000 for Accelerating Healing of COVID-19 Patients
